Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PERRIGO COMPANY PLC

(PRGO)
  Rapport
Vertraagde tijd Nyse  -  22:00 23-09-2022
38.09 USD   -1.35%
20/09US FDA zet zich in voor betere levering van zuigelingenvoeding
MT
14/09PERRIGO COMPANY PLC : Argus is nu positief gestemd over het aandeel
MM
12/09Perrigo zegt dat FDA in november orale anticonceptiepil voor vrij verkrijgbaar gebruik gaat beoordelen
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op PERRIGO COMPANY PLC
20/09US FDA Commits to Strengthening Infant Formula Supply
12/09Perrigo Says FDA to Review Oral Contraceptive Pill for Over-the-Counter Use in November
12/09U.S. FDA to review Perrigo's birth control pill for OTC use in November
12/09Perrigo announces joint fda advisory committee to review opillģ daily oral contraceptiv..
06/09Perrigo Company Shares Rise After Wells Fargo Upgrade
17/08Perrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Ov..
17/08Perrigo releases statement on recent market trading activity
17/08GSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
16/08Plaintiff in first Zantac lawsuit set for trial drops case
09/08PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
09/08Tranche Update on Perrigo Company plc's Equity Buyback Plan announced on November 8, 20..
09/08Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ende..
09/08Perrigo Cuts Full-Year Profit View on Currency Headwinds After Mixed Second-Quarter Res..
09/08PERRIGO : REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERAT..
09/08TRANSCRIPT : Perrigo Company plc, Q2 2022 Earnings Call, Aug 09, 2022
09/08Perrigo Company Reports Lower Q2 Earnings, Higher Sales; Revises Full Year Guidance
09/08PERRIGO : Q2 Earnings Snapshot
09/08Perrigo Company Revised Earnings Guidance for the Full Year of 2022
09/08Earnings Flash (PRGO) PERRIGO COMPANY Posts Q2 Revenue $1.12B
09/08Earnings Flash (PRGO) PERRIGO COMPANY Posts Q2 Loss $-0.48
02/08Perrigo announces quarterly dividend
02/08Perrigo Company plc Declares Quarterly Dividend, Payable on September 20, 2022
27/07Perrigo to release second quarter 2022 financial results on august 9, 2022
21/07Will A Nonprescription Birth Control Pill Be FDA's First Approval Under Its Long-Awaite..
15/07PERRIGO : Independent Auditors' Report - Form 8-K/A
15/07PERRIGO CO PLC Completion of Acquisition or Disposition of Assets, Financial Statement..
14/07PERRIGO CO PLC : Change in Directors or Principal Officers (form 8-K)
14/07Perrigo Company plc Appoints Albert A. Manzone to Serve as A Member of the Board of Dir..
11/07SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Monday
11/07Perrigo Unit Files Application With FDA for Switch to Over-The-Counter for Birth Contro..
11/07Perrigo Seeks FDA Over-The-Counter OK for Opill Birth-Control Pill
16/06Baby formula crunch in U.S. forces scramble to boost supplies
15/06TRANSCRIPT : Perrigo Company plc Presents at Oppenheimer 22nd Annual Consumer and E-Commer..
06/06Baby formula crunch in U.S. forces scramble to boost supplies
02/06Perrigo Company plc Promotes Alison Ives to Executive Vice President and Chief Scientif..
01/06ACTUALIZACIÓN DE LAS FUERTES VARIACI : Doc Martens le da una patada en el trasero a Zaland..
01/06Perrigo promotes alison ives to role of chief scientific officer
01/06U.S. needs more baby formula makers, Biden tells manufacturers
01/06POINT SUR LES FORTES VARIATIONS DU J : Doc Martens botte le derrière de Zalando
26/05Perrigo Secures FDA's Final Approval for Omeprazole Heartburn Treatment
26/05Perrigo Company plc Announces U.S. FDA Approval for Omeprazole Magnesium Delayed-Releas..
25/05TIMELINE : Baby formula crunch in U.S. forces scramble to boost supplies
20/05Baby formula crunch in U.S. forces scramble to boost supplies
19/05Perrigo to present at upcoming consumer investor conferences
17/05Face à la pénurie aux USA, Nestlé va importer des laits infantiles de Suisse
16/05U.S. to allow baby formula imports amid nationwide shortage
13/05Maker of Walmart, Amazon store-brand baby formulas sees shortages through rest of 2022
13/05US House Presses Baby Formula Makers on Steps Being Taken to Address Shortage
11/05PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
11/05Tranche Update on Perrigo Company plc's Equity Buyback Plan announced on November 8, 20..
11/05Perrigo Reports Mixed First-Quarter Results, Raises Full-Year Outlook
11/05SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Wednesday
11/05TRANSCRIPT : Perrigo Company plc, Q1 2022 Earnings Call, May 11, 2022
11/05Perrigo Reports Lower Fiscal Q1 Adjusted Earnings, Net Sales Climb; Raises Full-Year Ou..
11/05Former Fresh Del Monte Executive Joins Perrigo as CFO
11/05PERRIGO : Q1 Earnings Snapshot
11/05PERRIGO CO PLC : Change in Directors or Principal Officers, Regulation FD Disclosure, Fina..
11/05Perrigo Company plc Announces Retirement of Todd Kingma as Executive Vice President, Ge..
11/05Perrigo reports first quarter fiscal year 2022 financial results from continuing operat..
11/05Earnings Flash (PRGO) PERRIGO COMPANY Reports Q1 EPS $0.33, vs. Street Est of $0.42
11/05Earnings Flash (PRGO) PERRIGO COMPANY Reports Q1 Revenue $1.08B, vs. Street Est of $1.0..
11/05Perrigo Company plc Raises Earnings Guidance for the Fiscal Year 2022
11/05Perrigo Company plc Reports Earnings Results for the First Quarter Ended April 02, 2022
11/05Perrigo announces planned leadership succession
11/05Perrigo Company plc Announces Executive Changes
11/05Perrigo Company plc Appoints Eduardo Bezerra as Chief Financial Officer, Effective May ..
05/05Perrigo announces quarterly dividend
05/05Perrigo Company plc Declares Quarterly Dividend, Payable on June 21, 2022
02/05PERRIGO CO PLC : Completion of Acquisition or Disposition of Assets, Regulation FD Disclos..
02/05Perrigo completes the acquisition of hra pharma
29/04PERRIGO : ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA - Form 8-K
29/04Perrigo Company plc completed the acquisition of HRA Pharma, SA from funds affiliated w..
28/04PERRIGO CO PLC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
28/04Perrigo announces expected transaction close date of hra pharma
27/04Perrigo to release first quarter 2022 financial results on may 11, 2022
21/04SECTOR UPDATE : Health Care Stocks Edge Higher Pre-Bell Thursday
20/04Perrigo Closes $2.6 Billion of Senior Secured Credit Facilities
20/04PERRIGO : ANNOUNCES CLOSING OF $2.6 BILLION SENIOR SECURED CREDIT FACILITIES - Form 8-K
20/04PERRIGO CO PLC : Entry into a Material Definitive Agreement, Termination of a Material Def..
20/04Perrigo announces closing of $2.6 billion senior secured credit facilities
20/04Perrigo Company plc Announces Closing of $2.6 Billion Senior Secured Credit Facilities
04/04Perrigo Company Launches $500 Million Senior Notes Private Offering
04/04PERRIGO : ANNOUNCES LAUNCH OF PRIVATE NOTES OFFERING - Form 8-K
04/04PERRIGO CO PLC : Other Events, Financial Statements and Exhibits (form 8-K)
04/04Perrigo Announces Launch of Private Notes Offering
04/04Perrigo announces launch of private notes offering
28/03ALLIANCE PHARMA PLC - Acquisition to access US scar treatment market and expand Kelo-co..
28/03PERRIGO : Non GAAP Disclosure - Form 8-K
28/03PERRIGO CO PLC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits..
28/03Perrigo announces launch of syndication of new senior secured credit facilities
28/03Perrigo Company plc and Perrigo Investments Llc Announces Launch of Syndication of New ..
25/03Alliance Pharma Completes Purchase Of Silicone-based Scar Treatment Brand From Ireland'..
25/03Alliance Pharma plc acquired ScarAway and Kelo-cote from Perrigo Company plc for $19.4 ..
24/03Perrigo Company's CFO to Retire in July
24/03PERRIGO CO PLC : Change in Directors or Principal Officers (form 8-K)
24/03Perrigo announces cfo retirement and transition plan
24/03Perrigo Company plc Announces Planned Retirement of Ray Silcock as Chief Financial Offi..
24/03Perrigo Company plc Announces Planned Retirement of Ray Silcock as Executive Vice Presi..
18/03Perrigo announces u.s. fda approval for otc use of nasonex 24hr allergy
17/03Perrigo Gets Final US FDA Approval for Nasonex 24HR Allergy Switch to Over-The-Counter
Volgende evenement op PERRIGO COMPANY PLC